110 results on '"Kawamata, Futoshi"'
Search Results
2. Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
3. Reduced Port Laparoscopic TME with Coloanal Anastomosis
4. Preoperative FOLFOX in resectable locally advanced rectal cancer can be a safe and promising strategy: the R-NAC-01 study
5. Fluorescent Navigation Surgery for Gastrointestinal Tract Cancers: Detection of Sentinel Nodes, Tumor Tattooing, and Harvesting of Lymph Nodes
6. Proficiency Level of Novice Technically Qualified Surgeons in Laparoscopic Rectal Resection
7. Associating liver partition and portal vein ligation for staged hepatectomy as bridging therapy for liver transplantation in an infant with an advanced hepatic rhabdoid tumor.
8. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers
9. Laparoscopic dissection of perigastric lymph node metastasis from an unknown primary squamous cell carcinoma: a case report
10. Tumor budding and human chorionic gonadotropin-β expression correlate with unfavorable patient outcome in colorectal carcinoma
11. Human chorionic gonadotropin-β promotes pancreatic cancer progression via the epithelial mesenchymal transition signaling pathway
12. Comparison of Single-Incision Plus One Additional Port Laparoscopy-assisted Anterior Resection with Conventional Laparoscopy-assisted Anterior Resection for Rectal Cancer
13. C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma
14. Additional file 7 of Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
15. Additional file 9 of Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
16. Additional file 5 of Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
17. Additional file 8 of Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
18. Additional file 3 of Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
19. Additional file 4 of Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
20. Additional file 1 of Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
21. Additional file 2 of Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells
22. An increase in the peripheral lymphocyte-to-monocyte ratio after primary site resection is associated with a prolonged survival in unresectable colorectal carcinoma
23. Proficiency Level of Novice Technically Qualified Surgeons in Laparoscopic Rectal Resection
24. Reduced port surgery for UC
25. EGFR and Prion protein promote signaling via FOXO3a‐KLF5 resulting in clinical resistance to platinum agents in colorectal cancer
26. Early Transverse Colon Cancer Concurrent with Follicular Lymphoma: A Case Report
27. An increase in the peripheral lymphocyte-to-monocyte ratio after primary site resection is associated with a prolonged survival in unresectable colorectal carcinoma.
28. The anti-mesothelin monoclonal antibody amatuximab enhances the anti-tumor effect of gemcitabine against mesothelin-high expressing pancreatic cancer cells in a peritoneal metastasis mouse model
29. MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAFV600E mutation
30. Oncogenic BRAF mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia
31. Chorionic Gonadotropin-β Modulates Epithelial-Mesenchymal Transition in Colorectal Carcinoma Metastasis
32. Copy number profiles of paired primary and metastatic colorectal cancers
33. Mesothelin-Specific Immune Responses and Targeted Immunotherapy for Mesothelin-Expressing Tumors
34. The Balance Between Surgical Resident Education and Patient Safety in Laparoscopic Colorectal Surgery: Surgical Resident’s Performance has No Negative Impact
35. Abstract 5375: OncogenicBRAFmutation induces widespread DNA hypermethylation in a murine model for human serrated colorectal neoplasia
36. A Case of Carcinoid Tumor Arising in Meckel's Diverticulum
37. Intraoperative localization of arteriovenous malformation of a jejunum with combined use of angiographic methods and indocyanine green injection: Report of a new technique
38. Clinical impacts of mesothelin expression in gastrointestinal carcinomas
39. Does reduced‐port laparoscopic surgery for medically uncontrolled ulcerative colitis do more harm than good?
40. MLH1-93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAFV600E mutation.
41. Oncogenic <italic>BRAF</italic> mutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia.
42. RNF43 is mutated less frequently in Lynch Syndrome compared with sporadic microsatellite unstable colorectal cancers.
43. Importance of luminal membrane mesothelin expression in intraductal papillary mucinous neoplasms
44. Oncogenic BRAFmutation induces DNA methylation changes in a murine model for human serrated colorectal neoplasia
45. C-ERC/mesothelin provokes lymphatic invasion of colorectal adenocarcinoma
46. Clinical implications of luminal membrane expression of mesothelin in intraductal papillary mucinous neoplasms.
47. Does reduced-port laparoscopic surgery for medically uncontrolled ulcerative colitis do more harm than good?
48. Role of Percutaneous Transhepatic Biliary Endoprostheses with Distal Tube Implantation in the Subcutaneous Space for Management of Patients with Postoperative Biliary Stricture
49. Intracellular localization of mesothelin predicts patient prognosis of extrahepatic bile duct cancer
50. A Case of Right Paraduodenal Strangulated Hernia Concomitant with Intestinal Malrotation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.